Clinical Trials, Dr. Gordon, Dr. Rower, Dr. Teng, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, Underrepresented, University of Utah
Press Release: Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Stanford and MD Anderson Researchers Both Win CureAccelerator Live! for Pediatric Rare Diseases Clinical Repurposing Trials in Vascular Malformations and...
Adult, Clinical Trials, DEBRA Chile, Dr. Gordon, Dr. Rower, Dr. Teng, Drug, Oncology, Pediatric, Rare Disease, Stanford University, The University of Texas MD Anderson Cancer Center, Underrepresented, University of Utah
Press Release: Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Finalists Announced for Pediatric-Focused CureAccelerator Live! for Rare Diseases 2021 Competition Virtual Pitch Event on June 10 Features 4 Pediatric...
CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, Underrepresented
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
